Nurse Practitioner, Women’s Health · Munster, IN
NPI
1366581787
Since 2007
Specialty
Nurse Practitioner, Women’s Health
Code 363LW0102X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
9800 Valparaiso Dr
Munster, IN, 46321
Phone (219) 836-5800
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,518
58 services
Medicare patients, 2024
46
Average age 74
Drug cost, 2024
$40K
368 prescriptions
Company payments, 2025
$777
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca Papamihalakis was code 99213 (office e&m - established), 21 times for 20 patients. In total Rebecca Papamihalakis billed 58 services in 11 codes, and Medicare paid $1,518.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 21 | 20 | $28.20 | $592 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 11 | 11 | $29.79 | $328 |
By year: 2022 $9,077 for 230 services; 2023 $11K for 290 services; 2024 $1,518 for 58 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca Papamihalakis prescribed most often to Medicare patients was Estradiol, with 61 prescriptions and refills. In total Rebecca Papamihalakis wrote 368 Medicare prescriptions that cost $40K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 61 | 179 | 36 | $2,228 |
| Prempro Estrogen,con/M-Progest Acet | 46 | 83 | Under 11 | $20K |
| Alendronate Sodium Generic | 29 | 56 | Under 11 | $40.18 |
| Valacyclovir Valacyclovir Hcl | 18 | 35 | Under 11 | $445 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 18 | 19 | 15 | $348 |
| Fluconazole Generic | 17 | 17 | 14 | $46.56 |
| Acyclovir Generic | 13 | 35 | Under 11 | $99.41 |
| Estradiol (Twice Weekly) Estradiol | 11 | 25 | Under 11 | $1,429 |
| Myrbetriq Mirabegron | 11 | 11 | Under 11 | $5,144 |
Brand drugs: 76 claims; generic drugs: 292 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca Papamihalakis $777 ($777 in general payments such as food, travel and fees) from 13 companies. The largest payer was Mayne Pharma Commercial LLC with $190.
| Company | Payments | Amount |
|---|---|---|
| Mayne Pharma Commercial LLC | 10 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $114 |
| Exeltis, USA Inc. | 3 | $64.93 |
| Exact Sciences Corporation EXAS | 3 | $64.01 |
| Astellas Pharma US Inc 4503.T | 2 | $54.5 |
| Biogen, Inc. BIIB | 2 | $48.59 |
| Millicent US Inc | 2 | $44.35 |
| Organon LLC OGN | 2 | $41.44 |
| CooperSurgical, Inc. COO | 2 | $39.85 |
| Baxter Healthcare BAX | 1 | $39.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.